Literature DB >> 7506894

Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans.

E Blasi1, R Mazzolla, L Pitzurra, R Barluzzi, F Bistoni.   

Abstract

We have studied the effects of picolinic acid (PLA), a product of tryptophan degradation, on mouse susceptibility to intracerebral infection with Candida albicans. We show that intraperitoneal administration of PLA significantly enhances the median survival time of mice inoculated with the lethal challenge. Furthermore, intracerebral administration of this agent induces a protective state against the local lethal infection, the phenomenon depending upon the administration schedule and doses of PLA employed. According to survival data, yeast growth in the brain as well as yeast colonization of the kidneys are drastically reduced in PLA-treated mice compared with those for untreated controls. Northern (RNA) blot analysis of brain tissues demonstrates that mRNA levels specific for tumor necrosis factor and interleukin 1 are augmented and induced, respectively, after inoculation of PLA. These results indicate that PLA has a protective effect likely involving elicitation of a cytokine response in vivo against fungal infections.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506894      PMCID: PMC192402          DOI: 10.1128/AAC.37.11.2422

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Latex beads phagocytosis capacity and ecto-NAD+ glycohydrolase activity of rat brain microglia cells in vitro.

Authors:  V Bocchini; G Rebel; R Massarelli; F Schuber; C D Muller
Journal:  Int J Dev Neurosci       Date:  1988       Impact factor: 2.457

3.  In vivo activation of macrophages but not natural killer cells by picolinic acid (PLA).

Authors:  R Ruffmann; R D Welker; T Saito; M A Chirigos; L Varesio
Journal:  J Immunopharmacol       Date:  1984

4.  Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex.

Authors:  M P Heyes; B J Quearry; S P Markey
Journal:  Brain Res       Date:  1989-07-03       Impact factor: 3.252

5.  Candidal infection in the central nervous system.

Authors:  S A Lipton; W F Hickey; J H Morris; J Loscalzo
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

6.  Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain.

Authors:  R Schwarcz; W O Whetsell; R M Mangano
Journal:  Science       Date:  1983-01-21       Impact factor: 47.728

7.  Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed.

Authors:  P Gunning; P Ponte; H Okayama; J Engel; H Blau; L Kedes
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

8.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

Authors:  D Caput; B Beutler; K Hartog; R Thayer; S Brown-Shimer; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

Review 9.  Multiple microabscesses in the central nervous system: a clinicopathologic study.

Authors:  W W Pendlebury; D P Perl; D G Munoz
Journal:  J Neuropathol Exp Neurol       Date:  1989-05       Impact factor: 3.685

10.  Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome.

Authors:  M P Heyes; D Rubinow; C Lane; S P Markey
Journal:  Ann Neurol       Date:  1989-08       Impact factor: 10.422

View more
  10 in total

1.  Metabolomics reveals differential levels of oral metabolites in HIV-infected patients: toward novel diagnostic targets.

Authors:  Mahmoud A Ghannoum; Pranab K Mukherjee; Richard J Jurevic; Mauricio Retuerto; Robert E Brown; Masoumeh Sikaroodi; Jennifer Webster-Cyriaque; Patrick M Gillevet
Journal:  OMICS       Date:  2011-07-13

2.  Potent antifungal effects of a new derivative of partricin A in a murine model of cerebral cryptococcosis.

Authors:  T Luna; R Mazzolla; G Romanò; E Blasi
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

3.  Kynurenine pathway metabolites in humans: disease and healthy States.

Authors:  Yiquan Chen; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2009-01-08

4.  Enhanced resistance to Cryptococcus neoformans infection induced by chloroquine in a murine model of meningoencephalitis.

Authors:  R Mazzolla; R Barluzzi; A Brozzetti; J R Boelaert; T Luna; S Saleppico; F Bistoni; E Blasi
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

5.  Peripheral and central kynurenine pathway abnormalities in major depression.

Authors:  Elisabeth R Paul; Lilly Schwieler; Sophie Erhardt; Sandra Boda; Ada Trepci; Robin Kämpe; Anna Asratian; Lovisa Holm; Adam Yngve; Robert Dantzer; Markus Heilig; J Paul Hamilton; Martin Samuelsson
Journal:  Brain Behav Immun       Date:  2022-01-06       Impact factor: 19.227

6.  Anticryptococcal resistance in the mouse brain: beneficial effects of local administration of heat-inactivated yeast cells.

Authors:  E Blasi; R Mazzolla; R Barluzzi; P Mosci; F Bistoni
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  The kynurenine pathway and inflammation in amyotrophic lateral sclerosis.

Authors:  Yiquan Chen; Roger Stankovic; Karen M Cullen; Vincent Meininger; Brett Garner; Sarah Coggan; Ross Grant; Bruce J Brew; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2009-11-18       Impact factor: 3.911

8.  Biomolecular events involved in anticryptococcal resistance in the brain.

Authors:  E Blasi; R Barluzzi; R Mazzolla; L Pitzurra; M Puliti; S Saleppico; F Bistoni
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

Review 9.  The New Frontier of Host-Directed Therapies for Mycobacterium avium Complex.

Authors:  Nathan P Crilly; Samuel K Ayeh; Petros C Karakousis
Journal:  Front Immunol       Date:  2021-01-22       Impact factor: 7.561

10.  Kynurenine Pathway in Skin Cells: Implications for UV-Induced Skin Damage.

Authors:  Diba Sheipouri; Nady Braidy; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2012-07-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.